2nd Quarter - Report

MFJ INTERNATIONAL for MYLAN, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade issues related to generic medicines and biosimilars. Intellectual property provisions related to pharmaceuticals in the USMCA. Special 301 annual report.

Foreign entity interest: As parent entities of Mylan, Inc., Mylan NV and Mylan Holdings Limited have a general interest in the lobbying issues.

LobbyistCovered position, as disclosed
MARIA FABIANA JORGE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.